Sharon Lorek Vice President

Sharon Lorek, Vice President at NovaQuest Capital Management, has two decades of expertise in the pharmaceutical and biotech industry at a global level. She has broad operational and strategic experience across a range of therapeutic areas, stages of development, company types, and geographies. She is responsible for due diligence, structuring of investment opportunities, and post-close investment management.

Prior to joining NovaQuest, Ms. Lorek was a Global Project Leader at Chiesi Group, an international pharmaceutical company headquartered in Parma, Italy. During her tenure, she successfully led programs from development to FDA approval and launch, defined high-level strategies to maximize value for the commercial portfolio, and spearheaded a cross-functional R&D team to identify new therapeutic areas for inorganic long-term growth. Ms. Lorek also served in various project management and technical roles of increasing responsibility at Purdue Pharmaceuticals L.P., Schering-Plough Corp. (now Merk & Co.), Eon Labs Inc. (now Sandoz Inc.), and Corning Inc.

Ms. Lorek earned a BS in Chemical Engineering from North Carolina State University, and a Chiesi Corporate Maser from SDA Bocconi School of Management in Milan, Italy.

The information being provided is strictly as a courtesy. When you link to any of the websites provided here, you are leaving this website. We make no representation as to the completeness or accuracy of information provided at these websites, nor do we assume any risk of using such websites.

Proceed to Link